Sign in

You're signed outSign in or to get full access.

Steven Chaouki

Director at MAIA Biotechnology
Board

About Steven Chaouki

Steven M. Chaouki, age 52, serves as an independent Class I director at MAIA Biotechnology. He is President, U.S. Markets & Consumer Interactive at TransUnion and previously EVP, Financial Services; earlier roles included HSBC card/retail services and auto finance. He holds an MBA from the University of Chicago Booth School of Business and a bachelor’s degree from Boston University. He has served on MAIA’s board since at least 2021 and is designated as an audit committee financial expert .

Past Roles

OrganizationRoleTenureCommittees/Impact
TransUnionPresident, U.S. Markets & Consumer Interactive; previously EVP, Financial ServicesNot disclosed (in role since at least 2008 per prior proxy language)Oversees U.S. Markets and Consumer Interactive businesses; deep financial services domain expertise .
HSBCRoles in card/retail services and auto financeNot disclosedFinancial operations and consumer credit experience .

External Roles

OrganizationRolePublic Company DirectorshipNotes
TransUnionSenior executive (President, U.S. Markets & Consumer Interactive)Not disclosed as a directorExecutive role only; no MAIA-related transactions disclosed .

Board Governance

  • Board classification: Class I; term expires at the 2026 annual meeting; all directors except the CEO are independent; lead independent director is Stan V. Smith .
  • Committee memberships: Audit Committee member (chair: Louie Ngar Yee); Compensation Committee (Smith-Chair, Luput, Guerrero) and Nominating & Corporate Governance Committee (Louie-Chair, Luput, Smith) – Chaouki is listed only on Audit .
  • Attendance: Board held 4 meetings in 2024; all directors attended all Board meetings. Audit Committee held 4 meetings; all members attended all meetings .
  • Independence: Board determined all directors other than CEO Vlad Vitoc are independent (includes Chaouki) .

Fixed Compensation

ComponentPolicy/AmountTiming/VestingNotes
Director annual retainer (equity-only)$60,000 in stock options per year (11/15/2022–1/31/2025); increased to $100,000 in stock options per year starting 2/1/2025Granted quarterly in equal installments; options vest/distribute quarterlyNo cash fees; options valued at period-end closing price .
Committee chair/member equityAudit Chair: $15,000 options per year (pre-2/1/2025), then $7,500 options per year (from 2/1/2025); Comp and Nominating members: $5,000 options per year (from 2/1/2025)Quarterly grants and vestingChaouki is not a chair; he is an Audit member .
2024 actual board option grant (Chaouki)32,378 optionsDuring 2024Per non-employee director compensation table; no cash paid .

Performance Compensation

FeatureDetailsNotes
Performance metrics tied to director payNone disclosed for non-employee directorsDirector compensation is equity-only options with quarterly vesting; no specific performance metrics described .
Plan provisions (general)2021 Equity Incentive Plan allows performance shares/units, SARs, RSUs, optionsPlan permits performance-based awards, but director policy uses options; change-in-control actions at committee discretion .

Other Directorships & Interlocks

EntityTypeRelationship to MAIAPotential Interlock/Conflict
TransUnionPublic company; Chaouki is a senior executiveNo MAIA-related transactions disclosedNo related-party transactions involving Chaouki disclosed; independence affirmed .

Expertise & Qualifications

  • Financial and audit expertise: Designated audit committee financial expert; deep experience in financial services and consumer credit data .
  • Education: MBA, University of Chicago Booth; BA, Boston University .
  • Board qualifications: Management and financial expertise; independence .

Equity Ownership

HolderShares Owned (Common)Options/Warrants Exercisable Within 60 DaysTotal Beneficial Ownership% of Class
Steven Chaouki111,024151,578262,602Less than 1% .
  • Pledging/Hedging: Company insider trading policy prohibits hedging and pledging without pre-clearance; as of 12/31/2024, none of the directors or executives had pledged MAIA shares .

Insider Trades (Form 4 – Recent)

Filing DateTransaction DateTypeSecurityQuantityPricePost-Transaction Securities OwnedSEC Link
2025-10-062025-10-02Award (A)Stock Options20,946$1.8020,946https://www.sec.gov/Archives/edgar/data/1878313/000187831325000027/0001878313-25-000027-index.htm
2025-07-022025-06-30Award (A)Stock Options20,865$1.8020,865https://www.sec.gov/Archives/edgar/data/1878313/000112760225018656/0001127602-25-018656-index.htm
  • 2024 director purchases in company private placements (non-compensatory; issued under 2021 Plan as Unrestricted Stock Awards and Awards of Options at same terms as third-party investors): 34,641 shares ($~40,530) with 34,641 warrants (exercise $1.30); 22,133 shares ($~50,000) with 22,133 warrants (exercise $2.51) .

Governance Assessment

  • Strengths: Independent director; audit committee financial expert; perfect Board and Audit Committee attendance in 2024; engaged through equity participation in private placements alongside outside investors (alignment signal) .
  • Compensation: Equity-only option compensation (no cash), quarterly vesting; policy increased to $100k options from Feb 2025, supporting at-risk, equity-aligned pay; no performance metrics disclosed for directors .
  • Conflicts/Related Parties: No related-party transactions involving Chaouki disclosed; insider trading/hedging/pledging restrictions in place and no pledging as of 12/31/2024 .
  • Structure: Board is staggered; lead independent director in place; strong audit oversight with financial experts; potential investor dilution risk addressed elsewhere in proxy through authorized share increase rationale (not board-specific) .

RED FLAGS

  • None disclosed specific to Chaouki: no legal proceedings, no related-party transactions, no pledging, and full meeting attendance .